Vedanta Biosciences, Inc.   Report issue

For profit Phase 2 Phase 4
Founded: Cambridge MA United States (2010)

Organization Overview

First Clinical Trial
2017
NCT04236778
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Vedanta Biosciences | Vedanta Biosciences, Inc.